PAPER Iacoboni M, Baron JC, Frackowiak RS, Mazziotta JC, Lenzi GL
SEARCH RESULTS
348925 RESULTS
PAPER Bohrmann B, Tjernberg L, Kuner P, Poli S, Levet-Trafit B, Näslund J, Richards G, Huber W, Döbeli H, Nordstedt C
Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues.
J Biol Chem. 1999 Jun 4;274(23):15990-5. PubMed.PAPER Yu Q, Holloway HW, Utsuki T, Brossi A, Greig NH
Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
J Med Chem. 1999 May 20;42(10):1855-61. PubMed.PAPER Vernier JM, El-Abdellaoui H, Holsenback H, Cosford ND, Bleicher L, Barker G, Bontempi B, Chavez-Noriega L, Menzaghi F, Rao TS, Reid R, Sacaan AI, Suto C, Washburn M, Lloyd GK, McDonald IA
4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors.
J Med Chem. 1999 May 20;42(10):1684-6. PubMed.PAPER Findeis MA, Musso GM, Arico-Muendel CC, Benjamin HW, Hundal AM, Lee JJ, Chin J, Kelley M, Wakefield J, Hayward NJ, Molineaux SM
Modified-peptide inhibitors of amyloid beta-peptide polymerization.
Biochemistry. 1999 May 25;38(21):6791-800. PubMed.PAPER Yatin SM, Aksenova M, Aksenov M, Markesbery WR, Aulick T, Butterfield DA
Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.
J Mol Neurosci. 1998 Dec;11(3):183-97. PubMed.PAPER Greber S, Lubec G, Cairns N, Fountoulakis M
Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
Electrophoresis. 1999 Apr-May;20(4-5):928-34. PubMed.PAPER Langen H, Berndt P, Röder D, Cairns N, Lubec G, Fountoulakis M
Two-dimensional map of human brain proteins.
Electrophoresis. 1999 Apr-May;20(4-5):907-16. PubMed.PAPER Kaur G, Bhardwaj SK
The impact of diabetes on CNS. Role of bioenergetic defects.
Mol Chem Neuropathol. 1998 Aug-Dec;35(1-3):119-31. PubMed.PAPER Tytell M, Brown WR, Moody DM, Challa VR
Immunohistochemical assessment of constitutive and inducible heat-shock protein 70 and ubiquitin in human cerebellum and caudate nucleus.
Mol Chem Neuropathol. 1998 Aug-Dec;35(1-3):97-117. PubMed.PAPER Chalimoniuk M, Strosznajder JB
Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide.
Mol Chem Neuropathol. 1998 Aug-Dec;35(1-3):77-95. PubMed.PAPER Skau KA, Triplett CG
Age-related changes in activity of Fischer 344 rat brain acetylcholinesterase molecular forms.
Mol Chem Neuropathol. 1998 Aug-Dec;35(1-3):13-21. PubMed.PAPER Harkany T, Mulder J, Sasvári M, Abrahám I, Kónya C, Zarándi M, Penke B, Luiten PG, Nyakas C
N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity.
Neurobiol Dis. 1999 Apr;6(2):109-21. PubMed.PAPER Ferrer I, Rivera R, Blanco R, Martí E
Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease.
Neurobiol Dis. 1999 Apr;6(2):92-100. PubMed.PAPER Kikuchi M, Wada Y, Nanbu Y, Nakajima A, Tachibana H, Takeda T, Hashimoto T
EEG changes following scopolamine administration in healthy subjects. Quantitative analysis during rest and photic stimulation.
Neuropsychobiology. 1999 May;39(4):219-26. PubMed.Current Filters
No filters selected